Publication:
Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3

Simple item page
dc.contributor.coauthorHogas, S.
dc.contributor.coauthorBilha, S. C.
dc.contributor.coauthorBranisteanu, D.
dc.contributor.coauthorHogas, M.
dc.contributor.coauthorGaipov, A.
dc.contributor.coauthorCovic, A.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T12:12:43Z
dc.date.issued2017
dc.description.abstractCardiovascular disease is one of the main burdens of healthcare systems worldwide. Nevertheless, assessing cardiovascular risk in both apparently healthy individuals and low/high-risk patients remains a difficult issue. Already established biomarkers (e.g. brain natriuretic peptide, troponin) have significantly improved the assessment of major cardiovascular events and diseases but cannot be applied to all patients and in some cases do not provide sufficiently accurate information. In this context, new potential biomarkers that reflect various underlying pathophysiological cardiac and vascular modifications are needed. Also, a multiple biomarker evaluation that shows changes in the cardiovascular state is of interest. This review describes the role of selected markers of vascular inflammation, atherosclerosis, atherothrombosis, endothelial dysfunction and cardiovascular fibrosis in the pathogenesis and prognosis of cardiovascular disease: the potential use of cardiotrophin-1, leptin, adiponectin, resistin and galectin-3 as biomarkers for various cardiovascular conditions is discussed.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue4
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuEU
dc.description.sponsorshipCERO - CAREER PROFILE: Romanian researchers
dc.description.sponsorshipEuropean Social Fund Operational Programme Human Resources Development
dc.description.versionPublisher version
dc.description.volume13
dc.identifier.doi10.5114/aoms.2016.58664
dc.identifier.eissn1896-9151
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR01206
dc.identifier.issn1734-1922
dc.identifier.quartileQ2
dc.identifier.scopus2-s2.0-85020930989
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1185
dc.identifier.wos407268100024
dc.keywordsCardiovascular disease
dc.keywordsCardiotrophin-1
dc.keywordsAdipokines
dc.keywordsGalectin-3
dc.language.isoeng
dc.publisherTermedia Publishing
dc.relation.grantnoPOSDRU/159/1.5/S/135760
dc.relation.ispartofArchives of Medical Science
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/2478
dc.subjectMedicine
dc.subjectNephrology
dc.titlePotential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2478.pdf
Size:
127.62 KB
Format:
Adobe Portable Document Format
Download

Collections

Publications with Fulltext